研究目的
To discuss the potential biological impacts of liquid crystals in the diagnosis and prognosis of cancer along with the risk assessment, and to review the recent advances of liquid crystals in cancer biomarker detection and treatment in multiple cell line models.
研究成果
LC-based technologies hold great promise for the development of cancer screening and treatment options, but further research is needed to understand their molecular mechanisms and structure-activity relationships for the advancement of tumor-specific and high potential chemotherapeutic liquid crystal-based drug therapies.
研究不足
The review highlights the challenges in translating LC-based technologies into viable cancer diagnostics and treatment options, including the need for exhaustive studies on structure-activity relationships and molecular mechanisms of LCs, and the optimization of assays for clinical environments.